What is VOGX's current stock price?

VOGX (Vogenx Inc.) is currently trading at $19.08 with a market cap of $283.4M.

What sector is Vogenx Inc. in?

Vogenx Inc. (VOGX) operates in the Healthcare sector, specifically in the Biotechnology industry.

InvestLog

Back to Market返回行情

VOGX Vogenx Inc.

NASDAQHealthcare

$19.08-6.42%ClosedMarket Cap: $283.4M

As of 2026-10-22

Why VOGX matters now

Vogenx Inc. (VOGX) is a US stock in Healthcare. The latest InvestLog snapshot shows $19.08 with -6.42% on the session and $283.4M in market capitalization.

The latest indexable market news headline is "Vogenx Initiates Phase 2b EMERGE Study of Mizagliflozin for Post-Bariatric Hypoglycemia" from Accesswire.

Latest News

Vogenx Initiates Phase 2b EMERGE Study of Mizagliflozin for Post-Bariatric HypoglycemiaAccesswire · 2026-10-15

Vogenx Appoints Board Member Richard Gorman as Chief Commercial OfficerAccesswire · 2026-10-09

Vogenx Appoints Ken Toombs to Board of DirectorsAccesswire · 2026-09-22

Jones Served as Sole Book-Running Manager for Vogenx's $81.3 Million Initial Public OfferingPRNewsWire · 2026-08-17

Vogenx Announces Closing of Initial Public OfferingAccesswire · 2026-08-13

Company Info

Sector

Healthcare

Industry

Biotechnology

Country

Exchange

NASDAQ

Beta

0.00

Vogenx is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapeutics for the treatment of serious diseases associated with dysfunctions in human metabolism, including post-bariatric hypoglycemia (PBH) and gastroparesis. The company's lead product candidate is mizagliflozin, an orally administered, small molecule drug candidate being developed for the treatment of PBH, gastroparesis, and GIP-dependent Cushing's Syndrome.